Sveriges mest populära poddar
New Retina Radio by Eyetube
VetenskapTeknologi

The Art of Drug Choice: Phase 3 Trials in Wet AMD

32 min•19 november 2020

In episode 2 of the NRR miniseries “The Art of Drug Choice: Wet AMD and the Latest Data,” Dr. Khanani and roundtable participants Drs. Fuller, London, and Weng review the latest phase 3 efficacy data from the HAWK/HARRIER, ARCHWAY, and CEDAR/SEQUOIA studies. Also, Dr. Weng shares the case of a wet AMD patient whose response to therapy and toleration of treatment burden mandated a change in treatment. Could brolucizumab (Beovu, Novartis) be a solution? 


This editorially independent podcast is supported with advertising.

Fler avsnitt av New Retina Radio by Eyetube

Visa alla avsnitt av New Retina Radio by Eyetube
The Fellow Eye: Episode 6
•41 min
ASRS '26: SOL-1 and TRUCKEE at 4.5 Years
•24 min
New Retina Radio Journal Club w/ VBS: Clinical Features and Outcomes of IOFB Removal
•17 min
How EYP-1901 Addresses IL-6 Drivers in Wet AMD and DME
•29 min
Barriers to Care, Patient Education, and Treatment Decisions in Geographic Atrophy
•16 min
Evolving Practice Patterns and Dosing Strategies in Geographic Atrophy
•18 min
Biomarkers, Imaging, and Early Treatment Decisions in Geographic Atrophy
•14 min
The Fellow Eye: Episode 5
•39 min
Retinal Perfusion, Sensitivity, and Function in DR
•16 min
Spotlight on UNITY® VCS: Experience Extraordinary
•30 min

New Retina Radio by Eyetube med Retina Today finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.